Citeline Podcasts

In this edition of Device Week, Medtech Insight’s Reed Miller talks to managing editor Marion Webb about the growing interest among investors in "femtech," technology that specifically addresses women's health issues that have been frequently overlooked in the past. And London-based reporter Catherine Longworth addresses the recent media reports that Smith & Nephew may make a bid for spine-device company Nuvasive.

For more information on Medtech Insight and to start a free trial, click here.

Medtech Insight articles addressing topics discussed in this episode:

Market Intel: Let's Talk About It — The Rising Tide Of 'Femtech' Companies

Exec Chat: New Smith & Nephew CEO Namal Nawana Outlines Growth Strategy At JP Morgan

The burgeoning Medical Device Single Audit Program is the focus of this week’s podcast. Deputy editor Shawn M. Schmitt talks about the latest news on MDSAP and shares some tips for acing an MDSAP audit.

Medtech Insight articles addressing topics discussed in this episode:

• Canada's Switch From CMDCAS To MDSAP Went Off Without A Hitch – Despite 403 Firms Leaving The Market

• MDSAP Is A Snap If Your Firm Follows Quality Systems Standard ISO 13485, Auditor Says

• Compliance Corner: MDSAP Auditor Answers 5 Frequently Asked Questions

• Compliance Corner: 8 Handy Tips From An MDSAP Auditor To Help You Ace Your Next Audit

In this edition of Device Week, Medtech Insight's Catherine Longworth chats with Marion Webb about Livongo's acquisition of behavioral health company myStrength and with Reed Miller about the controversy surrounding the meta-analysis finding of a higher mortality risk with paclitaxel-eluting peripheral devices.

Listen to the podcast via the player below:

For more information on Medtech Insight and to start a free trial, click here:

http://bit.ly/2w7LnlR

Medtech Insight articles addressing topics discussed in this episode:

SCAI, Manufacturers Defend Peripheral Paclitaxel Devices Against Doubts

Livongo Buys Behavioral Health Firm in Multimillion Dollar Deal, Plans to Hire 300-500 People

On this week’s podcast, deputy editor Shawn M. Schmitt gives a roundup of recent Compliance Corner and Medtech Tips reports that featured combination drug-device product advice from quality experts at Eli Lilly and Johnson & Johnson.

Medtech Insight articles addressing topics discussed in this episode:

• Medtech Tips: Should A Combo Product-Maker's Quality System Be Device- Or Drug-Led? J&J, Eli Lilly Experts Weigh In

https://medtech.pharmaintelligence.informa.com/MT124525/Medtech-Tips-Should-A-Combo-ProductMakers-Quality-System-Be-Device-Or-DrugLed-JJ-Eli-Lilly-Experts-W

• Compliance Corner: J&J Quality Expert Urges Makers Of Combo Products To Be 'Bilingual' In Device- And Drug-Speak

https://medtech.pharmaintelligence.informa.com/MT124506/Compliance-Corner-JJ-Quality-Expert-Urges-Makers-Of-Combo-Products-To-Be-Bilingual-In-Device-And-Dru

• Compliance Corner: In Today's 24/7 World, Have Experts On Call For FDA Inspections, Eli Lilly Quality Director Says

https://medtech.pharmaintelligence.informa.com/MT124513/Compliance-Corner-In-Todays-247-World-Have-Experts-On-Call-For-FDA-Inspections-Eli-Lilly-Quality-Dir

• Compliance Corner: Having A Tight Grip On Suppliers Is Critical For Combination Product Manufacturers

https://medtech.pharmaintelligence.informa.com/MT124534/Compliance-Corner-Having-A-Tight-Grip-On-Suppliers-Is-Critical-For-Combination-Product-Manufacturers

In this edition of Device Week, Medtech Insight's Catherine Longworth chats with Marion Webb about some key takeaways at this year's JP Morgan Healthcare conference. That includes a Q&A with Smith & Nephew's new CEO, Namal Nawana on his growth strategy for the British medtech giant, new partnership announcements between medtech and tech companies, and trends in digital health.

Listen to the podcast via the player below:

For more information on Medtech Insight and to start a free trial, click here:

http://bit.ly/2w7LnlR

Medtech Insight articles addressing topics discussed in this episode:

Bringing A Digital Pill to Oncology: Proteus Partners With Health System To Prescribe Sensor-Enabled Chemotherapy

Exec Chat: New Smith & Nephew CEO Namal Nawana Outlines Growth Strategy At JP Morgan

Ascensia Inks Distribution Deal To Enter CGM Market

On this week's podcast, Ashley Yeo talks about a the "Long Term Plan" for the UK's health-care system published by the country's NHS this week, and the implications of Brexit. For more information about Medtech Insight and to sign up for a free trial go to bit.ly/2w7LnlR.

Medtech Insight articles addressing topics discussed in this episode:

NHS' New Plan: 'Long-Termism' Is Also Needed In Adoption And Spread Of Technology In UK: https://bit.ly/2D61q6T

ABHI 30: NHS Long-Term Plan Promises Diagnosis And Tech Uptake Boost For Industry And Patients: https://bit.ly/2FsOoSo

Brexit At The 11th Hour: UK Refreshes No-Deal Guidance For Medtech : https://bit.ly/2RJyfib

In this edition of Device Week, Medtech Insight’s Catherine Longworth reviews the year in mergers and acquisitions – including big moves by Medtronic, Stryker, and Boston Scientific. Looking forward to 2019, companies will be looking for acquisitions to help them take advantage of the emergence of Asia as the second-biggest device market, respond to Brexit, and potentially cope with new device regulations around the world.

For more information on Medtech Insight and to start a free trial, click here: https://bit.ly/2LPIfkC

Medtech Insight articles addressing topics discussed in this episode:

Boston Scientific's Drive To Add To Core Strength Continues With BTG Buy

https://invivo.pharmaintelligence.informa.com/IV124150/Boston-Scientifics-Drive-To-Add-To-Core-Strength-Continues-With-BTG-Buy

Major M&A Bookends Year Of Mainly Steady Growth For Leading Medtech Groups

https://scrip.pharmaintelligence.informa.com/SC124342/Major-MA-Bookends-Year-Of-Mainly-Steady-Growth-For-Leading-Medtech-Groups

Stryker Makes Big Investment In Spine Surgery With $1.4Bn K2M Acquisition

https://medtech.pharmaintelligence.informa.com/MT123208/Stryker-Makes-Big-Investment-In-Spine-Surgery-With-14Bn-K2M-Acquistion

Israel's Medtech Market Evolution: Seeking The Next Big Thing

https://invivo.pharmaintelligence.informa.com/IV124142/Israels-Medtech-Market-Evolution-Seeking-The-Next-Big-Thing

Deals and Financings

https://medtech.pharmaintelligence.informa.com/commercial/deals-and-financings

On this week’s podcast, senior reporter Elizabeth Orr gives a recap on the year in US legal news and how the courts impacted the medical device industry, from new Supreme Court justices Neil Gorsuch and Brett Kavanaugh to multimillion-dollar settlements in device safety cases – and much more.

Senior Medtech Insight Reporter Ferdous Al-Faruque talked about some of the discussions that took place at the summit and what they mean for industry. He opines what we can expect to see in 2019 and what industry should keep an eye on.

Researchers Apply Cancer Radiation To Cardiac Arrhythmia

In this edition of Device Week, Medtech Insight’s weekly podcast, managing editor Marion Webb gives an overview of physicians’ perspective of digital apps for diabetes patients and Deputy Editor Reed Miller discusses the early research into a potentially promising non-invasive radiation technique for treating ventricular tachycardia.

For more information on Medtech Insight and to start a free trial, click here.

Medtech Insight articles addressing topics discussed in this episode:

Market Intel: Managing Diabetes With Digital Apps: Physicians' Views On Pros And Cons

[The other one is coming soon]